This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
11 Jul 2014  |  Global  |  Market Research
Will Virtual CROs and Integrated Business Models Rule the Road
Insights into the innovative steps taken by CROs and pharmaceutical companies in the race for excellence and low-cost trials
This issue of Vital Signs, released on July 11, 2014, discusses game changing strategies in clinical research, including virtual clinical research organization (CRO) and the integrated business model.
$450.00 -
03 Jul 2014  |  Asia Pacific  |  Market Outlook
2014 Asia-Pacific Medical Devices Outlook
Changing Demographics and Landscape Set Stage for the Future
Medical devices plays a key role in a vibrant healthcare industry. An increasing aging population with increasing communicable and non-communicale diseases and most governments providing subisidized healthcare translate the need for cost-effective medical devices. Governments need to meet these expectations by policy librealization and revamping re...
$3,950.00 -
03 Jul 2014  |  Global  |  Market Research
A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS
Antiretroviral Combinations Continue to Transform the Treatment Landscape
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$3,950.00 -
01 Jul 2014  |  Global  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective - June 2014
This issue of Vital Signs, released on July 1, 2014, discusses the FDA approval of Biogens Eloctate, Qiagens acquisition of Primera Dx, Roches acquisition of Genia Technologies, Cues at-home connected lab test, and the Credihealth Teen Clinic.
$450.00 -
20 Jun 2014  |  Global  |  Market Research
Global Next-generation Sequencing Market
On the Verge of a Quadrupled Competitor Size and a Clinical Turning Point
The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research ser...
$10,000.00 -
11 Jun 2014  |  Global  |  Market Research
Analysis of the Western European Next Generation Sequencing (NGS) Market
Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...
$4,950.00 -
02 Jun 2014  |  Global  |  Market Research
Vital Signs - Healthcare News - The Analysts Perspective - May Issue
This issue of Vital Signs, released on June 2, 2014, discusses the latest strategy surrounding mega deals in the pharma/biotech industry, Eurofins agreement to acquire ViroCor-IBT Laboratories, Qiagens acquisition of BIOBASE, and the FDAs latest announcement on regulatory requirements for biosimilars.
$450.00 -
28 May 2014  |  Asia Pacific  |  Market Research
Profiling of Top 50 Healthcare Service Providers in Asia-Pacific
A Deep-dive Analysis of the Business and Financial Health of Leading Companies in the Region
Increased competition between healthcare providers which has lead to increased development of competitive features, such as premium care facilities, aesthetic and wellness medicine facilities, improved patient customer service, and so on. This has also stimulated the increased application of technology in both medical devices and information and c...
$4,950.00 -
26 May 2014  |  Asia Pacific  |  Market Research
Indonesian Infectious Disease IVD Market
Mapping the Market for Investment, Best Practices, and Growth Potential
The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...
$4,950.00 -
23 May 2014  |  Asia Pacific  |  Market Research
Western European Companion Diagnostics Market
Regulatory Hurdles and LDTs Stall the Global and European Market for Companion Diagnostics
The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...
$4,950.00